@ILROGTeam profile picture
ILROG Team @ILROGTeam
Joined July 2018
  • Tweets 285
  • Following 69
  • Followers 725
29 Photos and videos
ILROG Team retweeted
ASTRO
@ASTRO_org
13 May 2024
Read in the #RedJournal: For the 1st time, consolidation ISRT was randomly compared to IFRT in a phase III trial. Authors argue ISRT/INRT is safe and should thus remain the current standard of care in the setting of CMT of early stage Hodgkin lymphoma. bit.ly/rosenbrock1
10
20
4,275
Congratulations to our colleague and friend, #ILROG Steering Committee member @umbertoricardi on his #klassbreuraward at @ESTRO_RT this year! So deserved! #lymsm
1
4
20
1,168
ILROG Team retweeted
George Mikhaeel@GeorgeMikhaeel
20 Mar 2024
Should we extend breast cancer screening to Hodgkin Lymphoma patients treated with chemo only?? #radonc #lymphoma @ILROGTeam @becshakir @DavidJCutter
George Mikhaeel@GeorgeMikhaeel
20 Mar 2024
Doxurubicin increases breast cancer risk independent of age or RT! 1964 pts mFU 21.6 years. Survivors treated with >200 mg/m2 Dox had a 1.5-fold increased BC risk, cf no Dox. BC risk increased 1.18-fold per additional 100 mg/m2 Dox (Ptrend = .004). ascopubs.org/doi/10.1200/JCO…
2
2
6
1,648
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
4 Oct 2023
Last hurrah for #ASTRO23 sessions as a Social Champion! QP 19: Modernizing TBI First up - @brandon_imber looking at boom boom versus "big boom" 👉 many tx with definitive intent 👉 80% CR - but can take time! @ILROGTeam
2
4
14
1,438
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
3 Oct 2023
Replying to @UofT @HoppeBrad
Beatrice Fregonese @MSK_RadOnc @ILROGTeam presenting on primary gastric DLBCL 👉 higher RT doses by disease status 👉 no diff PFS/OS by chemo cycles or pre-RT disease status #ASTRO23
1
3
3
776
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
4 Oct 2023
Last but not least for the day: #HemeTeam @ASTRO_org/@ILROGTeam myeloma educational session! 👀 come join heme rad oncs with @ILROGTeam in Beijing! #ASTRO23
1
1
2
737
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
4 Oct 2023
Replying to @PennyFangMD
When to consider surgery? @ILROGTeam steering committee survey for dose in bone extramedullary #ASTRO23
2
1
354
ILROG Team retweeted
Bradford Hoppe@HoppeBrad
3 Oct 2023
Another ⁦@ASTRO_org⁩ #ASTRO23 means another CART related RT oral by ⁦@OmranSaifi⁩ Great Job ⁦@MayoFL_RORes⁩ @MayoRadOnc⁩ is proud!!
5
25
4,320
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
1 Oct 2023
Replying to @ILROGTeam
Fantastic use of advanced planning and excellent results without auto, with all G3/4 tox during induction. This ain't your grandparent's mantle RT - highly effective with negligble toxicity! Maybe we should look at transplant-free survival as a new endpoint? 🧐🤔 #ASTRO23
3
4
12
2,217
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
1 Oct 2023
Although BV-Nivo did the heavy lifting to CMR, reinforces the benefit of the rational integration of modern RT into evolving systemic therapy paradigms. With the support of groups like @ILROGTeam we can partner with our #HemeTeam colleagues #ASTRO23 @ASH_hematology
1
2
267
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
2 Oct 2023
👉 @ILROGTeam mini atlas is a fantastic resource for involved site rather than involved field 👉NLPHL behaved more like NHL 👉IMRT planning considerations 👉48 second maliginancies/471 patients #ASTRO23
1
2
3
322
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
1 Oct 2023
A little late, but made it to the @ASTRO_org @ILROGTeam joint session on challenging lymphoma cases! First up: challenging cases in abdominal/pelvic lymphomas with Dr. John Plastaras @PennRadOnc #ASTRO23
1
3
3
449
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
2 Oct 2023
Replying to @ILROGTeam
How to sim? 👉 Differences in breast position between arms up/down 👉 Benefits of breath hold 👉 Dose trapping when treating mediastinum/axilla - different priorities between men and women #ASTRO23
1
3
4
365
ILROG Team retweeted
Chelsea C Pinnix MD PhD@ChelseaPinnix
2 Oct 2023
Lots to learn at the @ASTRO_org & @ILROGTeam joint session. Practical pearls from @MDAndersonNews @BouthainaDabaja on how to simulate/plan axillary &mediastinal cases for ISRT. Limit dose to the lungs, heart & breasts!Arms down to spare the breast in females. DIBH is your friend.
3
22
1,260
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
2 Oct 2023
Replying to @ILROGTeam
How to plan these cases? ✅ mostly anterior beams ✅ lung V5 matters (sorry @jryckman3) ✅ dose constraints in the @NCCN #ASTRO23
1
2
7
1,081
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
2 Oct 2023
Fantastic and well attended #ASTRO23 @ASTRO_org @ILROGTeam educational session on challenging lymphoma cases featuring all the #lymsm #RadOnc royalty!
1
2
205
ILROG Team retweeted
Chelsea C Pinnix MD PhD@ChelseaPinnix
2 Oct 2023
Great presentation by @PennRadOnc John Plastaras on the management of challenging cases with RT. @ILROGTeam @ASTRO_org #ASTRO23 @JillGunther @LenaSpecht1
3
11
719
ILROG Team retweeted
Chelsea C Pinnix MD PhD@ChelseaPinnix
2 Oct 2023
Fun, informative & interactive @ILROGTeam & @ASTRO_org session led by @DrDHodgson. @BouthainaDabaja @JillGunther @LenaSpecht1 John Plastaras #ASTRO23
2
4
506
ILROG Team retweeted
Austin Sim, MD JD@A_CT_SimMDJD
2 Oct 2023
Replying to @ILROGTeam
Shifting to a mediastinal case - "lymphoma is like a balloon without invading" 💡 post chemotherapy! So less concerned with chasing microscopic disease, especially as these masses "retract" superiorly #ASTRO23
1
1
3
369
ILROG Team retweeted
George Mikhaeel@GeorgeMikhaeel
1 Oct 2023
AutoSCT no more required for low risk r/r cHL > BV-Nivo salvage? @HoppeBrad presented CheckMate 774 in #ASTRO2023 with 95% 3yPFS > RT consolidation with no AutoSCT in 28pts 5-30 ys. @ILROGTeam #radonc #hodgkin
18
42
6,136
Load more